BsAbs offer several advantages over traditional therapies:
Target specificity: They can precisely target cancer cells while sparing healthy tissues. Enhanced efficacy: By engaging multiple pathways or cell types, BsAbs can overcome resistance mechanisms that limit the effectiveness of monotherapies. Versatility: BsAbs can be tailored to target various combinations of antigens, making them adaptable to different types of cancers.
